AKT1 and ovarian cancer: The elevation in RGS17 expression resulted in a decrease in AKT activation followed by LPA treatment, thus illustrating the mechanism of growth arrest of ovarian cancer cells and the relevance of RGS17 expression in ovarian cancer cells.